“Uncovering Shareholder Rights: Levi and Korsinsky Launch Investigation into Business and Professional Services Sector”

Levi & Korsinsky Commences Investigation of Intellia Therapeutics, Inc. New York, NY / Access Newswire / January 26, 2025 Investigation of Intellia Therapeutics, Inc. Levi & Korsinsky notifies investors that it has commenced an investigation of Intellia Therapeutics, Inc. (“Intellia Therapeutics, Inc.”) (NASDAQ:NTLA) concerning possible violations of federal securities laws. Intellia issued a press release…

Read More

“Join the Class Action by March 25, 2025: Contact Levi and Korsinsky for Business and Professional Services”

Recovering Losses on Your Novo Nordisk A/S Investment Introduction For those who have recently suffered losses on their Novo Nordisk A/S (NYSE:NVO) investment, there may be potential opportunities for recovery under federal securities laws. If you find yourself in this situation, it’s essential to understand your rights and options moving forward. Understanding the Situation It…

Read More

“Calling All Business Buffs: Kros Alert! Levi and Korsinsky Launch Investigation on B-974031”

Welcome to the World of Stock Investigations! Investigating Keros Therapeutics, Inc. Hey there, fellow investor! Have you heard the latest news about Keros Therapeutics, Inc.? It seems like they’re in hot water with Levi & Korsinsky, who have just kicked off an investigation into possible violations of federal securities laws. Yikes! According to a press…

Read More